[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100356796":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":43,"locations":50,"responsibleParty":68,"collaborators":48,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":48,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":48,"enrollmentInfo":80,"targetDuration":48,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":48,"overallStatus":53,"whyStopped":48,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Folfox with avastin","ACTIVE_COMPARATOR","Folfox with avastin only",[13],"Drug: Folfox with avastin",{"label":15,"type":16,"description":17,"interventionNames":18},"Mebendazole","EXPERIMENTAL","Folfox with avastin with mebendazole",[19],"Drug: Mebendazole",[21,26],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],[25],"folfox 4",{"type":22,"name":15,"description":17,"armGroupLabels":27,"otherNames":28},[15],[29],"mebendazol",[31,35,37,40],{"name":32,"affiliation":33,"role":34},"Reham El-ghoneimy, Msc","Tanta University - Faculty of Pharmacy","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":33,"role":34},"Sahar Hegazy, Prof",{"name":38,"affiliation":33,"role":39},"Gamal el-azab, Prof","STUDY_DIRECTOR",{"name":41,"affiliation":5,"role":42},"Fatma Zakaria, Prof","STUDY_CHAIR",[44],{"name":45,"role":46,"phone":47,"phoneExt":48,"email":49},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440",null,"sheriefabdelsalam@yahoo.com",[51],{"facility":52,"status":53,"city":54,"state":48,"zip":48,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Sherief Abd-Elsalam","RECRUITING","Cairo","Egypt","EG",{"type":58,"coordinates":59},"Point",[60,61],31.24967,30.06263,{"lat":61,"lon":60},[64],{"name":65,"role":46,"phone":66,"phoneExt":48,"email":67},"Sherief Abd-elsalam, lecturer","00201000040794","Sherif_tropical@yahoo.com",{"type":69,"investigatorFullName":52,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":48,"oldOrganization":48},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100356796","phase-3-mebendazole-as-adjuvant-treatment-for-colon-cancer-100356796",false,"NCT03925662","Mebendazole as Adjuvant Treatment for Colon Cancer","Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer","Inclusion Criteria:\n\n* Colorectal cancer stage 4.\n\nExclusion Criteria:\n\n* Agranulocytosis\n* Pregnancy\n* Allergy to mebendazole.","ALL","18 Years",{"count":81,"type":82},40,"ESTIMATED","INTERVENTIONAL",[85],"PHASE3","mebendazole treating colon cancer",[88],"Colorectal Cancer","2019-04-22",{"date":91,"type":92},"2019-04-24","ACTUAL",{"date":94,"type":92},"2019-04-01",{"date":96,"type":82},"2028-12",{"name":52,"class":6},1]